SDZXF:OTCMKTS
Sandoz Group AG
US$Â 80.40
arrow_downward
-2.06%(-1.69) Siku 1
14 Sep, 16:00:00 GMT -4 · USD
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya SDZXF...
Fungua
US$Â 80.40
Juu
US$Â 80.40
Chini
US$Â 80.40
Mtaji wa soko
28.98B
Wastani wa kiasi cha mauzo
58.00
Kiasi cha mauzo ya hisa
elfu 2.00
Juu kwa wiki 52
US$Â 94.55
Chini kwa wiki 52
US$Â 55.50
Hisa za wawekezaji
440.00M
Idadi ya wafanyakazi
elfu 20
Fungua
US$Â 80.40
Juu
US$Â 80.40
Chini
US$Â 80.40
Mtaji wa soko
28.98B
Wastani wa kiasi cha mauzo
58.00
Kiasi cha mauzo ya hisa
elfu 2.00
Juu kwa wiki 52
US$Â 94.55
Chini kwa wiki 52
US$Â 55.50
Hisa za wawekezaji
440.00M
Idadi ya wafanyakazi
elfu 20
Wasifu
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Kuhusu Sandoz Group AG
Afisa Mkuu Mtendaji (CEO)Richard Saynor
Wafanyakazielfu 20
Lilianzishwa1886
Makao makuu-
Sekta-
Tovutisandoz.com